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Biological membranes are poised to later-
ally self organize, forming defined plat-
forms required for proper cell functioning. 
The lipid raft hypothesis postulates that 
specific lipid-lipid and lipid-protein inter-
actions can drive the formation of laterally 
segregated nanodomains, highly enriched 
in cholesterol (chol), in which membrane 
proteins are retained to perform their phys-
iological functions.[1,2] Those chol-enriched 
nanostructures are highly packed, in con-
trast to the rest of surrounding lipids, 
which form a more fluid phase. Lipid 
raft have been described to be involved in 
practically all biological functions and are 
associated with various human diseases 
(i.e., cancer, neurodegenerative diseases).[3] 
This lateral membrane heterogeneity has 
been extensively validated and visualized 
at the microscale using model membrane 
systems and in silico simulations where 
the lipid composition is easy to adjust.[4] 
Despite more than 20 years of work since the lipid raft concept was proposed, 
the existence of these nanostructures remains highly controversial due to 
the lack of noninvasive methods to investigate their native nanorganization 
in living unperturbed cells. There is an unmet need for probes for direct 
imaging of nanoscale membrane dynamics with high spatial and temporal 
resolution in living cells. In this paper, a bioorthogonal-based cholesterol 
probe (chol-N3) is developed that, combined with nanoscopy, becomes a 
new powerful method for direct visualization and characterization of lipid 
raft at unprecedented resolution in living cells. The chol-N3 probe mimics 
cholesterol in synthetic and cellular membranes without perturbation. When 
combined with live-cell super-resolution microscopy, chol-N3 demonstrates 
the existence of cholesterol-rich nanodomains of <50 nm at the plasma 
membrane of resting living cells. Using this tool, the lipid membrane 
structure of such subdiffraction limit domains is identified, and the nanoscale 
spatiotemporal organization of cholesterol in the plasma membrane of 
living cells reveals multiple cholesterol diffusion modes at different spatial 
localizations. Finally, imaging across thick organ samples outlines the 
potential of this new method to address essential biological questions that 
were previously beyond reach.
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However, in living cells composed of a broad variety of lipids 
and proteins, lipid raft remains elusive (or illusive).[5] Since 
seeing is believing, lack of direct visualization of nanoscale lipid 
heterogeneity in the plasma membrane (PM) of living unper-
turbed cells increases the skepticism towards the real existence 
of lipid raft.[6] The astonishing improvement in optical micro-
scopy resolution over the last decades has permitted visualizing 
single molecules at the nanometer scale. Current super-reso-
lution fluorescence microscopy (SRM) techniques have, by far, 
overcome the spatial diffraction-limit and allowed for direct 
observation of cellular processes with high temporal and spatial 
resolution in living cells.[7,8] However, despite strong advances in 
SRM allowing to trap and visualize biological processes at the 
nanoscale, direct imaging of lipid nanodomains is hampered by 
the rapid diffusion of lipids and their short lifetime within in 
vivo cell membranes.[9] The main drawback is that SRM tech-
niques require longer acquisition times and high probe photo-
stability, which often can only be attained by cell fixation.[10] 
Although cell fixation works relatively well with proteins it is of 
limited application when using lipids or lipid probes.[11] Recently, 
environment-sensitive probes compatible with SRM have been 
developed and tested in living cells. However, when combined 
with SRM, these Nile-Red-based probes did not prove the exist-
ence of lipid heterogeneity in the plasma membrane of living 
cells but only a higher degree of order in outward and inward 
protrusion, suggesting a direct association of curvature with 
order.[12]Authors could not rule out that the presence of even 
low amounts of the probes does not impact lipid dynamics and 
domain formation. Similarly, the use of another solvatochromic 
dye named Di-4-ANEPP combined with STED nanoscopy 
has enabled to visualize and quantify nano- and micrometric 
domain dynamics (>100 nm). However, those solvatochromic 
dyes only inform about membrane order state without giving 
accurate information about the lipid and protein composition 
of those domains.[8] Alternatively, secondary ion mass spectro-
metry has shown to be a valuable technique to visualize the 
micro- and nanoscale lateral organization of cellular mem-
branes in situ. Nevertheless, this technique is performed under 
ultra-high vacuum and requires sample fixation.[13] To date, 
lipid chemical tools used to study lipid membranes have not 
addressed the features of lipid raft and chol dynamics in living 
cells at the nanoscale, and the challenge to develop membrane 
lipid probes suitable for live-cell SRM remains unachieved.
To address the aforementioned need, we chose to develop a 
bioorthogonal chol probe (chol-N3) that preserves the natural 
molecule’s physicochemical properties and shows outstanding 
performance in SRM. Our approach enables direct visualization 
and characterization of nanoscale lipid heterogeneity at the PM 
of living unperturbed cells. Chol-N3 facilitates direct imaging 
of membrane lipid dynamics with high spatiotemporal resolu-
tion over extended time scales and areas with an unprecedented 
level of detail. When combined with fluorescence microscopy, 
chol-N3 permits 3D deep visualization of chol distribution 
through thick brain tissue samples. We conclude providing a 
PM model containing yet unknown features of nanoscale chol 
dynamics in living cell membranes.
2. Results and Discussion
2.1. Synthesis, Design, and Characterization of the Chol Probe
To investigate the existence of chol-rich nanodomains in living 
cells, we undertook the synthesis of a chol chemical probe, chol-
N3, based on bioorthogonal chemistry that can be used to explore 
many unknown features of lipid raft in living cell membranes. 
We reasoned that chemical probes for imaging lipid heteroge-
neity and dynamics should contain a latent chemical modifica-
tion that minimally perturbs the biophysical and metabolical 
properties of the chol probe. Bioorthogonal chemistry has shown 
widespread usage in the past, offering unique advantages over 
other chemical reactions such as 1) versatility and selectivity, 
2) compatibility with all types of biomolecules, and 3) suitability 
for live-cell imaging. With this idea in mind, we introduced 
an unobtrusive azide group in position 24 of the chol mole-
cule (Figure  1A). The preparation of chol-N3 is fully described 
in the Experimental Section. We first started by investigating 
the natural behavior of the chol probe compared to its endog-
enous counterpart. In silico experiments show that the absolute 
stereochemistry and molecular topology in a hydrophobic envi-
ronment exhibited by chol-N3 are very similar to those observed 
in unmodified natural chol (Figure 1B). Next, we evaluated the 
suitability of the chol-N3 probe for imaging purposes in living 
cells. To this end, living cortical neurons pre-treated with chol-
N3 were labeled by copper-free click chemistry using a fluores-
cently-labeled dibenzocyclooctyne (DBCO) containing a linker 
between the dye and the reacting group, and were visualized. 
Confocal imaging of chol-N3 in living neurons demonstrates 
intense chol-N3 staining, which is particularly robust in the 
soma, axon, and dendrites (Figure S1 and Movie S1, Supporting 
Information). Cell labeling with a series of DBCO-linked fluo-
rescence dyes differing in size and polarity showed a similar 
labeling pattern, ruling out any possible artifact that could be 
attributed to the fluorescent dye used (Figure  S2, Supporting 
Information). Marginal labeling was observed when cells were 
grown in the presence of ethanol (vehicle) instead of chol-N3 
(Figure S3, Supporting Information). Finally, neither chol-N3 
nor the fluorophore-labeled cyclooctyne treatment exert any 
toxic effect on the cultured cells (Figure S4, Supporting Infor-
mation). These results validate the use of the new probe for live-
cell imaging. Recently, a similar labeling strategy has enabled 
visualization of mitochondrial phosphatidylcholine containing 
lipids in living cells by confocal microscopy.[14]
To assess whether the chemical modification introduced 
in this probe interferes with the native behavior of the natural 
compound, and to verify that decoupling the dye from the mole-
cule by a linker buffers the fluorophore’s overall impact on lipid 
behavior, we carried out a series of control experiments designed 
to compare the biophysical behavior of chol-N3 (nonlabeled and 
labeled) to that of chol in model and cell membranes. First, we 
used the solvatochromic fluorescent probe Laurdan to detect 
changes in membrane lateral packing properties due to its 
ability to sense the polarity of the surrounding environment.[15,16] 
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To this end, we prepared large unilamellar vesicles of 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) 
containing Laurdan in the presence of chol, chol-N3, or chol-
N3 labeled with Alexa Fluor 647-DBCO (AF 647-DBCO). As 
observed in Figure 1C, the generalized polarization value (GP)[17] 
shows the same membrane condensation or order behavior 
irrespective of the chol analog used. Next, we investigated the 
ability of chol-N3 to induce lipid membrane domains in model 
membranes. For this purpose, giant unilamellar vesicles 
(GUVs) composed of the ternary mixture POPC/Sphingomy-
elin (SM)/chol, known to phase separate into liquid-disordered 
(low chol content, Ld) and liquid-ordered (high chol content, 
Lo) domains, were used.[18] To examine the partitioning of 
endogenous chol as well as chol-N3 in GUVs, Rhodamine-PE 
and naphthopyrene were used as Ld and Lo markers, respec-
tively. As Figure 1D shows, similar phase separation and domain 
formation were observed with chol and chol-N3. Importantly, 
when the labeling experiments were carried out in situ using 
Alexa Fluor 488-DBCO (AF 488-DBCO), the fluorescently-labeled 
chol-N3 showed strong localization in the Lo phase (Figure S5, 
Supporting Information), probing that the lipid labeled using a 
dye with a linker has an identical phase separation to the native 
form. Finally, we performed Langmuir Trough interfacial experi-
ments to quantify the area per molecule occupied by our dye 
at meaningful membrane surface pressures (≈30 mN m−1).[16] 
Addition of dye at the interface showed minimal displacement 
of the area ocupied by a single dye in comparison with dipal-
mitoylphosphatidylcholine (DPPC), a saturated lipid forming 
Figure 1. A) Molecular structures of the chol probe (chol-N3) (left) and chol (right). B) In silico lowest energy structures of chol-N3 and chol (displayed 
as space-filling structures) in a hydrophobic environment. C) Temperature-dependent generalized polarization (GP) profiles of LUVs composed of 
POPC:chol (90%:10%)(●), POPC:chol-N3 (90%:10%)(●), and POPC:chol-N3:chol-N3-AF 647-DBCO (90%:8%:2%)(●) containing 5 × 10−6 m Laurdan. 
D) Partitioning characteristics of lipids in phase-separated GUVs composed of DOPC/SM/chol (3:3:1, mol:mol) (top) or DOPC/SM/chol-N3 (3:3:1, 
mol:mol) (bottom) labeled with 0.2% Rho-DHPE (red, left panel), and 0.5% naphthopyrene (NAP) (blue, middle panel). These probes label the Ld phase 
and the Lo phase, respectively. Overlay images of the two different channels are shown in the right panel. Scale bar = 5 µm. E) Monolayer experiments 
at 30 mN m−1. A chol (3.25 × 10−8 mol) monolayer was programmed to maintain a 30 mN m−1 surface pressure prior to adding a 1% (black) of chol-
N3-AF647, or a 1% molar ratio of DPPC (red) as a positive control. Area per molecule is normalized to 1% chol-N3-AF647. Increased area per molecule rep-
resents an increase of area made to maintain the 30 mN m−1 surface pressure. Lipids addition that minimally changes the area per molecule at 30 mN m−1 
indicates that the presence of the dye is not affecting native chol biophysical function. N = 3 independent experiments were completed per condition.
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Lo domains, indicating that the labelled chol occupied a smaller 
area than a DPPC molecule and could be accomodated without 
monolayer area disruption (Figure 1E). Altogether, these results 
point to similar lateral lipid packing distribution, chain order, 
and membrane organization in model membranes containing 
either chol or its chemical analog chol-N3, both nonlabeled 
or labeled with Alexa Fluor dyes containing a linker sepa-
rating the lipid from the reporter dye. Finally, we investigated 
whether chol-N3 and chol follow the same intracellular uptake 
pathway. To this end, we performed an in vivo competition assay 
in cells where the concentration of chol-N3 was kept constant 
while increasing the concentration of free chol in the media. 
As observed in Figure S6 (Supporting Information), increasing 
levels of extracellular chol block the uptake of chol-N3 gradu-
ally, which is virtually abolished at 500 × 10−6 m chol. When the 
same experiment was repeated with chol-N3 previously labeled 
with AF 488-DBCO, identical results were obtained to those 
observed with the unlabeled lipid analogue (Figure S7A, Sup-
porting Information), thus confirming that chol-N3 (labeled or 
unlabeled) follows the same intracellular uptake pathway as 
chol in vivo. Strikingly, when the commonly used BODIPY-chol, 
where the fluorophore is directly linked to the lipid, was used 
instead of labeled or unlabeled chol-N3, no competition effect 
was observed (Figure S7B, Supporting Information), suggesting 
a different cellular uptake mechanism between the BODIPY-
labeled lipid and the parental molecule. Overall, the performed 
experiments show that chol-N3, labeled or nonlabeled, behaves 
like its endogenous counterpart and is highly suitable for live-
cell imaging. Notably, the results prove that dye labeling to the 
chol backbone by means of a linker does not change the phys-
ical/chemical properties of the host lipid. These results are in 
complete agreement with previous studies showing that the 
presence of a linker between the target lipid and the dye mini-
mizes the dye’s impact on lipid’s physicochemical properties.[19]
2.2. Unraveling Nanoscale Lipid Heterogeneity  
in Resting Living Cells
Having validated the new chol probe, we started imaging chol-
rich nanodomains in resting living cells. Hence, we combined 
our chemical probe with stimulated emission depletion (STED) 
fluorescence nanoscopy, a broadly used SRM technique to spa-
tially resolve in higher detail (≈50 nm) biological processes at the 
nanoscale.[20] Living cells treated with chol-N3 were labeled with 
AF 488-DBCO and visualized by 2D STED nanoscopy. Although 
fluorescent labeling of chol-N3 before cellular membrane addi-
tion also shows great properties as previously demonstrated, it 
is important to mention that the major advantages of labeling 
the lipid after cellular uptake are 1) the lipid can be inserted, 
distributed along cellular membranes, and fluorescently labeled 
at different time points and 2) since the fluorescent-labeled dye 
is cell nonpermeable, it allows to label only PM chol and to 
image it for a short time, removing chol fluorescence coming 
from intracellular structures, a process that cannot be avoided 
when an already fluorescently labeled lipid is administrated to 
cells. As Figure 2A,B shows, resolution of chol spatial distribu-
tion along the PM of living cells is highly improved in STED 
compared to standard confocal microscopy (LSCM) and enables 
high detail observation of nanoscale lipid heterogeneity in the 
plasma membrane of living cells. Close-up images (Figure 2C) 
reveal nanodomains with ∼20–40 nm size as quantified by 
measuring the “Full Width at Half Maximum” (FWHM) value 
of the fluorescent intensity line profiles (Figure 2D). Statistical 
analysis of the chol-enriched nanodomain size distribution 
by measuring their lateral width[21] revealed two well-defined 
Gaussian peaks at 48 and 157 nm, and a broad single peak 
distribution in the domain shape, measured by the lateral 
sphericity (Figure  2E,F). Overall, these indicate that chol-rich 
nanodomains are highly heterogeneously distributed across the 
PM and differ in size and morphology. Similar lipid heteroge-
neity with sizes well below the diffraction-limit was observed 
when primary neuronal cells were studied (Figure  3A–C). To 
ensure that lipid heterogeneity observed in Figure  2 was not 
an effect of dye aggregation due to the probe and reporter mol-
ecule concentrations used, we repeated the same experiment 
progressively decreasing the concentration of chol-N3 and AF 
488-DBCO. As observed in Figure S8 (Supporting Information), 
even a twenty-fold reduction of both molecule´s concentration 
allows the visualization of similar highly STED-resolved punc-
tuate chol-rich nanodomains in living cell surfaces. When the 
same experiment was repeated using two different dyes dif-
fering in structure (AF 488 is based on a fluorescein scaffold, 
whereas AF 555 and AF 647 use cyanines as building blocks) 
and degree of hydrophobicity (Figure  S9A,B,C Supporting 
Information), similar lipid heterogeneity was observed when 
cells were visualized by STED nanoscopy (Figure S9D,E, Sup-
porting Information). Finally, to validate that the imaged lipid 
heterogeneity corresponds to GPI-associated lipid nanodo-
mains, we performed two-color SRM in living cells using the 
chol probe combined with a classical lipid raft marker, the 
glycosylphosphatidylinositol-anchored (GPI-anchored) protein 
CD59, a protein involved in signaling processes.[22] Cells trans-
fected with CD59-SNAP were treated with the chol probe. Pro-
tein and lipid were labeled in situ using cell SNAP-Surface AF 
647 and AF 488-DBCO, respectively, and visualized by LSCM 
and STED microscopy (Figure  S10A–C, Supporting Informa-
tion). As observed in Figure S10D (left panel, Supporting Infor-
mation), the colocalization map shows a strong fluorescent 
signal correlation between the CD59 and the chol molecule. 
This high degree of colocalization was further confirmed when 
the colocalization coefficient was calculated (Figure S10E, left 
panel, Supporting Information). Considering that the max-
imum colocalization coefficient obtained for chol imaged in 
the confocal versus STED mode was 0.814 (Figure  S10D,E, 
right panels, Supporting Information), the results show that 
more than 75% of GPI-anchor CD59 protein localize into chol-
enriched nanodomains in the cell surface of resting living cells. 
The above results confirm that the lipid heterogeneity observed 
in Figure  2 is a direct visualization of GPI-associated chol-
enriched nanodomains in the plasma membrane of living cells.
Given the high lateral resolution and probe photostability 
achieved with 2D STED, we asked whether the plasma mem-
brane’s lateral organization could also be super-resolved 
in the axial plane. This three-dimensional spatial arrange-
ment is critical to fully determine nanodomains morpholo-
gies and identify cellular factors (i.e., cytoskeleton) regulating 
PM lipid heterogeneity. To test this, we combined chol-N3 
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with 3D STED nanoscopy. 3D STED recording of living cells 
showed that lipid nanodomains could be super-resolved in 
the axial plane (Figures 2G and 3D). Figure 2G (right panel) and 
Figure 3C,D show that lateral lipid organization could be resolved 
laterally down to 89 nm and axially down to 107 nm, in contrast to 
deconvolved confocal (d-LSCM) images that showed domain sizes 
of ≈180 and ≈600 nm, respectively. To the best of our knowledge, 
this is the first time that chol-rich nanodomains have been directly 
observed within the membrane of living unperturbed cells with 
such high resolution in all three planes (XY resolution ≈ 25–35 
Figure 2. A) Super-resolution STED microscopy of chol-rich nanodomains in the PM of living SH-SY5Y cells treated with 25 × 10−6 m chol-N3 for 16 h 
and labeled with 12.5 × 10−6 m AF 488-DBCO. The 2D-STED in vivo super-resolution image of chol-N3 distribution in living cells clearly shows the pres-
ence of nanoscopic domains in the PM. B) Super-imposed image of PM chol-N3 distribution in living cells visualized by both conventional deconvolved 
confocal (LSCM) and STED nanoscopy. C) White squared insets (i–iii) in (B) are magnified, showing that the spatial resolution of chol nanodomains 
viewed in the STED mode (red) is much higher than that obtained using confocal mode (green). The color bars indicate the image brightness and the 
numerals at the red and green scale bars indicate the dynamic range. D) Representative fluorescence intensity profiles measured along the solid white 
line 1 in (A) showing STED resolution improvement with nanodomains <40 nm. Lines in black and red show LSCM and STED, respectively. E) Gaussian 
peak fits population distribution width and F) sphericity of membrane lipid heterogeneity throughout the PM. G) Left panel: representative 3D confocal 
(green) and STED (red) microscopy images of chol-N3 distribution at the PM of living SH-SY5Y cells. Right panel: 3D-STED overview image showing 
the orthogonal view (planes XY, ZX, and ZY). White arrows point to single chol nanoscale domain size across the ZY and ZX planes.
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and ≈110 nm in the Z-axis) and in accordance with their pre-
dicted lateral size in living cells.[23]
2.3. Revealing Lipid Heterogeneity and Nanoscale Dynamics  
in Living Cell Membranes
Next, we tried to unravel the membrane lipid structure of such 
lipid nanodomains in living cells. Lateral organization of the 
cellular membrane is known to be formed by the clustering of 
specific lipids into different domains, which are immiscible 
among them. Highly-condensed domains are differentiated 
from the surrounding membrane by their lipid structure (Lo 
vs Ld).[1,24,25] To study if the previously observed nanoscale 
lateral organization in the PM corresponds to Lo domains 
as in model membranes, we combined the chol probe with 
Laurdan, a solvatochromic lipophilic probe highly sensitive to 
changes in the lipid lateral packing properties and the gold-
standard of lipid order quantification. This polarity sensitive 
probe partitions ubiquitously into both phases, shifting its 
spectral emission properties when it is localized in a more 
densely packed lipid membrane.[26,27] Cells were treated in vivo 
with the chol probe combined with Laurdan. After imaging, 
the GP map was calculated, and the resolved GP values were 
displayed as a histogram (Figure 4A,B). The GP map, as well 
as the distribution of GP values, clearly show nonarbitrary 
differences in GP values across the cell surface. However, 
areas with high GP values, indicating a condensed structure, 
colocalize with the chol-enriched nanodomains labeled with 
the chol probe (Figure  4C). Notably, Figure  4C also shows 
that chol-enriched nanodomains also exist in more disor-
dered regions. However, when a large number of chol-rich 
Figure 3. 2D and 3D d-LSCM and d-STED microscopy of nanoscale lipid heterogeneity distribution across cortical neurons. A) Cortical neurons were 
treated with chol-N3 (15 × 10−6 m, 16 h) and subsequently labeled in vivo with AF 488-DBCO (10 × 10−6 m, 30 min) and visualized by conventional 
d-LSCM (top green image) or d-STED nanoscopy (bottom red image). The color bar indicates the image brightness and the numerals at the red and 
green scalebar indicate the dynamic range used. B) Super-imposed image of chol-N3 distribution in living neurons visualized either by conventional 
confocal (LSCM) or STED microscopy showing an enhancement of the resolution by d-STED compared to d-LSCM. C) White squared insets (i–iii) in 
panel B are magnified, and further magnification of regions (a–h) is performed, (enclosed within dotted yellow lines (i–iii)) showing nanoscale chol 
distribution. White arrows point to single chol nanodomains structures and their size; yellow arrows point to chol intensive points. D) 3D LSCM and 
STED nanoscopy of selected area iv in panel B (red box) displaying lateral and axial lipid heterogeneity distribution in living neurons. The 3D image on 
the left was obtained using a LSCM (green), while the 3D image on the right was obtained using a STED (red) microscope. White arrows in ZX and 
ZY orthogonal views point to chol nanodomain structures whose sizes were highly resolved (size values displayed in red) when STED nanoscopy was 
used instead of LSCM (size values displayed in green). Representative images of n = 5 independent experiments.
Small Methods 2021, 5, 2100430
www.advancedsciencenews.com www.small-methods.com
2100430 (7 of 15) © 2021 The Authors. Small Methods published by Wiley-VCH GmbH
nanodomains were analyzed, the majority of those nanodo-
mains show a Lo distribution (4.3 ± 0.093 Lo-like domains per 
micron2 with an average area of 0.003 ± 0.0008 per micron2). 
Since the emission of Laurdan partially overlaps with the 
absorption of AF 488, we checked that FRET between the 
two dyes was not taking place, which could affect GP values. 
As observed in Figure S11A,B (Supporting Information), nei-
ther a significant quenching of AF 488 to Laurdan emission in 
ethanol or liposomes, nor important variation in GP values in 
liposomes at two different temperatures, were detected ruling 
out any significant FRET between the two dyes. Besides, when 
the same living cell experiment was repeated using Laurdan 
and AF 647-DBCO, whose emission and absorption spectra 
are well-separated, identical results were obtained, showing 
a strong colocalization between the chol labeled probe and 
the Laurdan ordered channel at 440 nm (Figure S11C–F, 
Supporting Information). These results demonstrate that as 
hypothesized in lipid raft, chol-rich nanodomains laterally 
segregate into condensed lipid structures that differ in the 
degree of fluidity from the rest of the PM in living cells. It is 
important to mention that the strategy used here has a major 
advantage over other approaches that have been used to mon-
itor membrane lipid order.[12,24] Unlike studies that only used a 
single probe to analyze plasma membrane lipid compartmen-
talization, the combination of chol-N3 and a solvatochromic 
probe used here enables us not only to probe nanoscale lipid 
heterogeneity in living cells in an unbiased way, but also to 
ascertain that the Lo structures observed are highly-enriched 
in chol; the key constituent of lipid raft.
2.4. Nanoscale Spatiotemporal Diffusion Dynamics of chol-N3 
in Living Cells
An additional long-standing question in membrane biology is 
to unravel the nanoscale spatiotemporal organization of lipids 
within the PM. In other words, is chol diffusion through these 
ordered nanodomains slower than diffusion along more fluid 
areas at the PM? We addressed this experimental challenge 
by combining the chol probe with line interleaved excitation 
scanning STED Fluorescence Correlation Spectroscopy (LIESS-
FCS) in live cells, as recently described.[28] Molecular diffusion 
dynamics at different spatiotemporal localizations can be meas-
ured by LIESS-FCS in one single measurement using fast and 
multiple scanning across a line (alternating STED and confocal 
laser illumination) with minimal invasion (Figure  5A). The 
ratio between the diffusion coefficient by STED and confocal 
yields the Drat value. As previously reported,[28] a Drat value 
close to 1 indicates free diffusion, whereas Drat values <1 are 
characteristic for trapped molecules. Chol diffusion was calcu-
lated in living cells at different PM localizations and the cor-
responding autocorrelation function for each focal spot was 
used to build up the correlation carpets in either confocal or 
STED nanoscopy (Figure  5B). Interestingly, two different dif-
fusion modes were observed for chol across the same zone 
(dotted white-line frame). When the chol transit time is sim-
ilar within a diffraction-limited (STED) and a larger (confocal) 
illumination spot, then Drat is lower than 1, thus suggesting 
a trapped molecular diffusion (Figure  4B, red arrows) with a 
lipid-specific transient trapping time between 4 and 12 ms and 
Figure 4. A) Lipid nanodomains structure characterization in cells treated with chol-N3 (15 × 10−6 m) labeled with AF 488-DBCO and combined with 
Laurdan (5 × 10−6 m). Overall maximum intensity projection (top left) and intensity heat map (bottom left) of chol-N3 distribution. Laurdan raw confocal 
image in the ordered (440 nm) (top right) and disordered (490 nm) (bottom right) channels. B) Generalized polarization (GP) (top) and Laurdan GP 
value histogram (bottom). C) White squared insets (i,ii) in (B) and their corresponding GP histograms. White circles marked as (b) (region i) and (d) 
(region ii) correspond to chol-N3 nanodomains in an ordered environment. However, white circles marked as a (region i) and (c) (region ii) correspond 
to chol-N3 nanostructures in a more disordered environment.
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an average diffusion coefficient of D = 0.13 ± 0.04 µm2 s−1. In 
addition, we also observe a 500 nm region (dotted white-line 
frame), where the chol resident time was shorter in STED 
mode (Figure  5B, blue arrows). In this case, the Drat  ≈1 value 
strongly suggests a free diffusion mode for chol with an average 
diffusion coefficient of D  = 1.26 ± 0.05 µm2 s−1. Overall, chol 
transit time quantification shows a chol spatial and temporal 
heterogeneity where chol in free and trapped diffusion modes 
coexist within a nanoscale area. These dual slow chol diffu-
sion modes have been previously observed only using in silico 
methods, but never in live cells showing visual presence of lipid 
nanodomains.[29] Reassuringly, our results indicate that the 
existence of high-ordered and less ordered lipid nanodomains 
in vivo is highly dependent on the chol content (Figure 5C,D). 
It is important to mention that when a larger number of chol-
enriched areas are analyzed, the most abundant chol diffusion 
mode is the trapped mobility, as the one depicted in the histo-
gram of Figure 5C. Finally, we determined the average number 
of chol labeled molecules trapped in ordered lipid nanodomains 
and freely diffusing through a less-ordered nanodomain within 
the PM. This is a significant challenge in cell biology, where 
the concentration and aggregation state of lipids may differ in 
Figure 5. A) Spatial and temporal resolution of nanoscale lipid heterogeneity in SH-SY5Y cells treated with chol-N3 (15 × 10−6 m) for 16 h, labeled with 
AF 488-DBCO and imaged by LIESS-STED-FCS. Overall confocal images of chol-N3 in the PM of living cells. B) Representative correlation carpet of 
the simultaneous confocal and STED recordings from lines 1–3 selected in (A). Red and blue arrows point to chol diffusion in trapped (Drat < 1) and 
free (Drat = 1) modes, respectively, coexisting along the same region (white dotted box). C) Drat values for each transit time obtained confirming the 
existence of two major chol diffusion modes, where trapping lateral mobility is more abundant than free diffusion. D) Numbers of chol-N3 molecules 
trapped and free diffusing across ordered and disordered domains in the PM of live cells.
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various localizations and change during biological processes. 
To this end, we quantified the molecular brightness[30] allowing 
us to calculate the apparent average number of molecules in 
each pixel from our series of LIESS-FCS-STED measurements. 
From our STED measurements, we found an average number 
of 59.14 ± 0.65 molecules of confined chol-labeled probe and 
16.76 ± 0.1 molecules freely diffusing through the investigated 
area (Figure 5D). Since potential background signal (e.g., noise, 
internalized fluorescence) can affect molecular brightness 
measurements, we tested whether chol-N3 signal in the PM 
was stable over time. As observed in Figure S12A, (Supporting 
Information), chol-N3 labeled with AF488-DBCO fluorescence 
signal in the PM is very stable with no photobleaching or loss 
of fluorescence over long-time measurements. However, fluo-
rescence intensity fluctuations were observed in intracellular 
vesicles filled with chol-N3 (Figure S12A, Supporting Informa-
tion). To confirm these results, we performed raster imaging 
correlation spectroscopy (RICS) experiments of the chol-N3 
probe in the PM of living cells. RICS allows tracking biomol-
ecule diffusion in living cell membranes in space and time 
simultaneously at large regions of interest.[8,31] Hence, it ena-
bles us to move across wide length and temporal scales. As 
Figure S12B, Supporting Information, shows chol-N3 labeled 
with AF488-DBCO fluorescence intensity is very stable over 
time and fast and slow chol-N3 diffusions through the PM can 
be detected in agreement with our LIESS-STED-FCS results. 
These findings shed new light into the complex heterogeneous 
nature of cell membranes in real-time, showing that while the 
majority of chol is trapped into ordered nanodomains, chol is 
also found to form less-ordered and diffusible domains through 
the PM of living cells.
2.5. 3D Volumetric Mapping of Chol Distribution  
in Intact Tissue
Visualizing single lipid species at high-resolution in tissues has 
been difficult, especially in the brain, where large concentra-
tions of lipids and chol can be found. We tried to map chol dis-
tribution above the cellular level, by studying if high-resolution 
images of tissues or even complete organs could be obtained. 
Our starting hypothesis was that given the chol probe’s unique 
properties in living cells, this could help to visualize the 3D chol 
organization in thick brain samples by fluorescence microscopy 
without the need to slice the sample into thin serial sections. 
For this purpose, thick rat brain slices, varying in thickness 
from 500 µm to 1 mm, were labeled ex vivo with the chol probe. 
Figure 6A shows a 3D volumetric reconstruction of thick brain 
slices where the cells were densely and homogenously labeled 
throughout the sample. These results are in good agreement 
with the expected general chol distribution through brain cells 
(i.e., oligodendrocytes and astrocytes).[32] To further corrobo-
rate the localization of chol-enriched structures in the plasma 
membrane, we treated the brain samples with a fluorescently 
labeled lectin, a well-known plasma membrane marker. We 
found a strong colocalization between the chol probe and the 
plasma membrane marker (Figure  6A; Movie S2, Supporting 
Information). On the other hand, in the absence of chol-N3 
treatment, no fluorescence labeling through the tissue was 
observed (Figure S13, Supporting Information). Finally, we tried 
to determine to what extent the high-resolution visualization of 
chol in deep-tissue structures was possible. To this end, repre-
sentative sections of rat brain cortex were imaged at high mag-
nification by confocal microscopy. With different objectives, we 
were able to obtain 3D volumetric reconstructions of magni-
fied areas where the distribution of chol in brain cells is clearly 
shown (Figure 6B).
Overall, through the design and development of a bioorthog-
onal-based chol probe that retains similar physicochemical 
properties compared to the parental molecule when fluores-
cently labeled and performs superbly in SRM, we have pro-
vided compelling evidence about the existence of lipid raft in 
the cell surface of living unperturbed cells, a long-lasting mys-
tery in science. Using the chol probe we could answer many 
remaining biological questions about lipid nanoscale hetero-
geneity in cells. We have recapitulated these new biological 
data in a PM model (Figure 7). When the probe was combined 
with SRM in living cells, we could directly observe and charac-
terize PM nanoscale heterogeneity with domain sizes far below 
the diffraction limit in all three planes (XY  ≈ 25–35 nm with 
2D STED and ≈ 110 nm in the Z-axis, 3D-STED) (Figures  2 
and  3). Compared to other methods that supported the exist-
ence of lipid raft by indirect evidence, either tracking fluores-
cently labeled proteins that, supposedly, populate such lipid 
structures[33] or by chol depletion using pharmacological drugs 
and chemicals as methyl-β-cyclodextrins, which seems to affect 
cellular architecture,[34] here we directly observed their native 
nanoscale organization in the PM of living cells in a noninva-
sive manner. Performing dual-color live-cell SRM, we observed 
a strong enrichment of a classical lipid raft marker, the GPI-
anchor protein CD59, with chol in the cell surface of living 
cells (Figure S10, Supporting Information). A previous study 
using protein micropatterning combined with single-molecule 
tracking of GFP-tagged GPI anchor proteins showed that GPI-
anchor proteins do not reside in Lo domains in the cell sur-
face of cells.[35] However, recent works using a combination 
of fluorescent lipid nanodomain markers and single-molecule 
tracking obtained similar results to our work where GPI-anchor 
proteins colocalize with a classical lipid raft marker, the gan-
glioside GM1, for different periods in the PM of living cells.[36] 
These contradictory results can be explained by the fact that 
in micropatterning experiments, GFP-GPI anchor proteins 
expressed in cells are immobilized to streptavidin enriched cov-
erslips using a biotinylated GFP antibody, and this process may 
change the protein’s physicochemical properties and thus affect 
how the protein interacts with other PM components and the 
cytoskeleton. When we combined the chol probe with an envi-
ronment-sensitive probe, we ascertained that the lipid struc-
ture of the observed nanodomains was mainly a Lo structure 
(Figure  4; Figure S11, Supporting Information). Those results 
are in accordance with previous studies that determined using 
environment-sensitive probes and SRM that the PM is mainly 
composed of 76% ordered and 24% disordered lipid domains.[27] 
However, in our living cell experiments, a highly complex 
picture of cellular membrane organization emerged, where 
distinct chol-enriched nanodomains with different degrees 
of order coexist. This has been previously observed in model 
membranes[37] but not in live cells. The LIESS-FCS-STED 
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Figure 7. PM model illustrating nanoscale lipid heterogeneity features. The model shows the relevant biological data such as nanodomains size, shape, 
order, and membrane dynamics uncovered in this work. ∅: diameter, e: ellipticity, D: average diffusion coefficient.
Figure 6. In-depth chol distribution in the brain. A) 3D volumetric reconstruction of a rat brain slice (700 µm) treated with chol-N3 (500 × 10−6 m) for 
2 h, washed and subjected to cycloaddition reaction with sulfo-cy3-DBCO (50 × 10−6 m) for 3 h. PM and nuclei were labeled using WGA-AF 488 and 
Hoechst, respectively. The full 3D reconstruction is available in movie S5, Supporting Information. B) 3D volumetric reconstructions of selected cortex 
regions (blue and orange squared insets) showing high-resolution distribution of chol-N3 across the brain cortex.
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experiments with the probe shed new light on the organization 
of chol-rich nanodomains by revealing different degrees of chol 
lateral mobility in real-time within the membrane depending 
on its partition between highly-ordered (where chol is trapped 
with a retention time >4 ms) and less-ordered domains (where 
chol diffuses freely with retention times <4 ms). However, as 
observed with the lipid structure experiments, when a large 
number of nanodomains were analyzed, the majority of nano-
domains showed a Lo structure and trapped state (Figure  4). 
Interestingly, similar retention times (>4 ms) to the ones found 
in this work were observed using scanning STED-FCS for 
lipids showing a trapped mode.[38] Quantifying the molecular 
brightness from the LIESS-FCS-STED recordings enables us 
to determine the number of chol labeled molecules present in 
an ordered (≈60 molecules) and less ordered (≈17 molecules) 
nanodomain.
A striking example that could not be answered without the 
chol-N3 probe is provided by the generation of high-resolution 
3D volumetric images showing the distribution of chol through 
thick brain sections by confocal microscopy in an unprece-
dented manner and highlights its versatility for tissue imaging. 
This methodology could be further extended to investigate the 
effects of chol on tissue or organ development in vivo by fluo-
rescent microscopy. The approach described in this work has 
some limitations that have to be considered. For instance, the 
molecule has to be administrated exogenously to cells, and 
labeling using a reporter dye containing a linker could change 
some properties of the labeled lipid. While our strategy using 
a linker between the lipid and the reporter molecule buffers 
the impact of the dye in the physicochemical properties of chol 
(Figure  1; Figure S5, Supporting Information), enabling us to 
track chol at the nanoscale (Figures  2, 3, and  5), we can not 
rule out a direct effect of the labeling at the atomistic level. In 
this sense, molecular dynamics simulation studies could clarify 
whether the reporter molecule’s presence alters how the labeled 
lipid interacts with surrounding biomolecules at the atomistic 
level. Finally, due to the versatility of click chemistry, the chol-
N3 present within cells and tissues can also be modified by any 
molecule bearing an alkyne or cyclooctyne group that could 
serve as a functional tool for future in vivo studies using a wide 
range of techniques, such as cryo-correlative light and electron 
microscopy and magnetic resonance imaging.
3. Conclusions
In this work, we developed chol-N3, a bioorthogonal-based chol 
probe that, when combined with SRM, provides direct visualiza-
tion of nanoscale lipid heterogeneity in the cell surface of resting 
living cells. The chol-N3 offers a new dimension to study the 
impact of lipid raft in fundamental biological processes in living 
cells with high spatial and temporal resolution over extended time 
scales and areas. For instance, chol-N3 can be combined with a 
wide range of dyes compatible with live-cell SRM imaging or with 
fluorescently labeled biomolecules (i.e., proteins). This strategy 
proficiently facilitates the study of the implication of nanoscale 
lipid heterogeneity in a large number of cellular processes such as 
receptor signaling, trafficking, and unraveling the role of actin as 
a direct orchestrator of plasma membrane compartmentalization 
since it offers the unique ability to track biomolecules by dual-
color live-cell SRM directly. Finally, this bioorthogonal probe 
opens up new avenues for the in-depth investigation of chol 
tissue organization and its impact on health and disease.
4. Experimental Section
The following lipids were purchased from Avanti lipids (Alabaster, 
AL): 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine (DOTAP), 1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine (DOPE), Bodipy-chol (TopFluor-chol) and 
cholesterol (Chol). Lissamine Rhodamine B 1,2-Dihexadecanoyl-
sn-Glycero-3-Phosphoethanolamine (Rho-PE) and Cholera Toxin B 
conjugated to Alexa Fluor 647 were purchased from ThermoFisher 
Scientific (Waltham, Massachusetts, Ma). Naphtho[2,3a-]pyrene (NAP) 
was purchased from Sigma-Aldrich (St. Louis, MO). Alexa Fluor 
488-DBCO (AF 488-DBCO), Alexa-Fluor 555-DBCO (AF 555-DBCO), 
Alexa-Fluor-647-DBCO (AF 647-DBCO) and sulfo-Cyanine3-DBCO (sulfo-
cy3-DBCO) were purchased from click chemistry tools (Scottsdale, AZ). 
pME-puro-SNAP-FLAG-CD59 was a gift from Reika Watanabe (Addgene 
plasmid # 50374; http://n2t.net/addgene:50374; RRID:Addgene_50374).
Synthesis of Compounds—General Procedures: All reagents were 
obtained from Sigma-Aldrich, Fisher Scientific, or TCI and used 
without further purification. Anhydrous N,N-dimethylformamide, 
Tetrahydrofuran, dichloromethane were purchased in sealed bottles 
and stored over molecular sieves. Deuterated solvents were purchased 
from Fisher Scientific. Solvents were removed on an IKA Rotavapor 
RV10 equipped with an ILMVAC LVS210TE vacuum pump. Thin layer 
chromatography was performed with silica 60 Å gel TLC plates from 
Merck (60 F254) and analyzed by UV illumination or 20% sulfuric acid 
staining solution. High-pressure NMR spectra were acquired on Bruker 
AV-500. 1H NMR spectra were referenced to residual CHCl3 (7.26 ppm). 
13C NMR spectra were referenced to CDCl3 (77.16 ppm). NMR spectra 
were processed using MestReNova (Mestrelab Research S.L.). High-
resolution ESI mass spectra of small molecules were obtained at the 
University of the Basque Country (EHU/UPV) Mass Spectrometry 
Facility on a Thermo LTQ Orbitrap mass spectrometer.
Synthesis of Compounds—Experimental Procedures: Synthesis of 
4-(3-((tert-butyldimethylsilyl)oxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13, 
14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic 
acid 1): Compound 1 was synthesized as previously described in [39] with 
slight modifications. Briefly, in a three-neck bottom flask containing a 
solution of 3β-hydroxy-5-cholenic acid (0.305 g, 0.814 mmol) in DMF 
(7 mL) at 0 °C was subsequently added Imidazole (0.445 g, 6.54 mmol), 
DMAP (0.200 g, 1.64 mmol), and TBDMSCl (0.370 g, 2.45 mmol). The 
solution was stirred overnight at room temperature. After stirring 
overnight, the reaction was quenched with 1 m HCl (5 mL) and extracted 
with EtOAc. The organic layer was washed with brine dried over MgSO4, 
and the solvent was removed under reduced pressure. Next, the crude 
product was dissolved in 14 mL MeOH/THF (1/1, v/v) and a 10% (w/w) 
K2CO3 (4 mL) solution was added in water. After stirring for 1 h at room 
temperature, the reaction mixture was concentrated under reduced 
pressure. The product was resuspended in 25 mL brine and acidified to 
pH 3 with 1 m HCl. Finally, the compound was extracted with EtOAc (3 × 
50 mL), dried over MgSO4 and concentrated in vacuo. The crude product 
was purified using silica gel chromatography (hexanes: diethyl ether: 
acetic acid, 70:30:1 v:v:v) to afford a white solid. Yield: 0.345 g (87%).
1H NMR (CDCl3, 500 MHz) δ = 5.32 (m, 1H), 3.49 (tt, J = 10.9, 10.9, 
4.7, 4.7, 1H), 2.40 (m, 1H), 2.31– 2.23 (m, 2H), 2.17 (m, 1H), 1.98 (m, 2H), 
1.91–1.67 (m, 4H), 1.64–1.24 (m, 10H), 1.20–1.03 (m, 4H), 1.00 (s, 3H), 
0.94 (d, J = 6.5, 3H), 0.89 (s, 9H), 0.68 (s, 3H), 0.06 (s, 6H). 13C NMR 
(CDCl3,126 MHz): −4.59 (x2), 11.86, 18.26, 18.29, 19.42, 21.05, 24.25, 
25.94 (x3), 28.09, 30.78, 30.90, 31.91 (x2), 32.08, 35.31, 36.58, 37.39, 39.77, 
42.39, 42.81, 50.17, 55.75, 56.77, 72.65, 121.12, 141.57, 179.83 ppm. HRMS 
(ESI) calcd for C30H52NaO3S: 511.3583 [M+Na]+; found: 511.3576.
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Synthesis of 4-(3-((tert-butyldimethylsilyl)oxy)-10,13-dimethyl-
2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]
phenanthren-17-yl)pentan-1-ol (2): Compound 2 was synthesized as 
described in[39] with minor modifications. In a 100 mL bottom flask 
containing a slurry solution of LiAlH4 (0.120 g, 3.16 mmol) in THF (5 mL) 
at 0 °C was added dropwise a solution of (1) (0.340 g, 0.6962 mmol) 
in THF (20 mL). The reaction mixture was allowed to warm to room 
temperature and stirred for 1.5 h. Next, at 0 °C the reaction mixture 
was quenched with subsequently dropwise addition of H2O (110 µL), 
15% NaOH (110 µL), and H2O 322 µL. After 1 h, the granular salt 
was filtered off, the organic layer washed with brine, dry over MgSO4 
and concentrated in vacuo. The crude product was purified by column 
chromatography (hexanes: EtOAc (85/15 v:v) to afford a withe yellowish 
solid. Yield: 0.265 g (80%).
1H NMR (CDCl3, 500 MHz) δ = 5.32 (dt, J = 4.5, 2.0, 2.0, 1H), 3.49 
(m, 1H), 2.40 (m, 1H), 2.27 (m, 2H), 2.17 (m, 1H), 2.02–1.94 (m, 2H), 
1.91–1.77 (m, 2H), 1.75–1.64 (m, 1H), 1.63–1.33 (m, 7H), 1.33–1.24 (m, 
8H), 1.00 (s, 3H), 0.94 (d, J = 6.6, 4H), 0.89 (s, 9H), 0.68 (d, J = 1.7, 4H), 
0.09 (s, 1H), 0.08 (d, J = 0.9, 1H), 0.06 (s, 6H). 13C RMN NMR (CDCl3, 
126 MHz,) δ = 141.72, 121.27, 72.80, 56.91 × 2, 55.90, 50.32, 42.96, 42.54, 
39.92, 37.54, 36.73, 35.46, 32.22, 32.05 (x2), 29.84, 28.24, 26.09 (x3), 
24.40, 21.20, 19.57, 18.88, 18.44, 18.41, 12.01, −4.44 (x2).




phenanthren-17-yl)pentyl methanesulfonate (3).To a solution of 
(2) (0.270 g, 0.49 mmol) in dry CH2Cl2 (25 mL), neat ET3N (0.075 g, 
0.74 mmol) was added dropwise at 0 °C. The resulting mixture was 
vigorously stirred for 15 min, followed by dropwise addition of neat 
MsCl (0, 085 g, 0.74 mmol). After stirring for 3 h at 0 °C, the reaction 
mixture was diluted by addition of CH2Cl2 (10 mL). The organic layer 
was successively washed with 0.5 n HCl (20 mL), aqueous sat. NaHCO3 
(20 mL), and brine (20 mL), dried over MgSO4, filtered and concentrated 
under reduced pressure. The crude product was purified by flash 
chromatography (hexane/ethyl acetate 2/1) to afford compound 3 as a 
white powder. Yield: 0.260 g (96%).
1H NMR (CDCl3, 500 MHz) δ  = 5.32 (m, 1H), 4.23–4.18 (m, 2H), 
3.48 (m, 1H), 3.00 (s, 3H), 2.27 (m, 1H), 2.17 (m, 1H), 2.03–1.94 (m, 2H), 
1.88–1.76 (m, 3H), 1.74–1.38 (m, 8H), 1.26 (s, 6H), 1.16–1.06 (m, 3H), 
1.00 (s, 3H), 0.95 (d, J = 6.5, 3H), 0.89 (s, 9H), 0.68 (s, 3H), 0.06 (s, 6H). 
13C NMR (CDCl3, 126 MHz) δ = 141.57, 121.10, 72.62, 70.66, 56.77, 55.99, 
50.16, 42.81, 42.36, 42.34, 39.77, 37.40, 37.38, 36.57, 35.29, 32.08, 31.89, 
31.52, 29.69, 28.20, 25.83, 24.23, 22.69, 19.42, 18.55, 11.85, −4.59. HRMS 
(ESI) calcd for C31H56NaO4SSi: 575.3566 [M+Na]+; found: 575.3558.
Synthesis of 17-(5-azidopentan-2-yl)-10,13-dimethyl-
2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]
phenanthren-3-ol (4). To a three-necked round, bottom flask fitted with 
a reflux condenser was added a solution of (3) (0.200 g, 0.36 mmol) 
in anhydrous DMF (5 mL). To the resulting solution, NaN3 (0.094 g, 
1.44 mmol) was added portion wise under argon atmosphere, and 
the resulting mixture was stirred overnight at 80 °C. After cooling 
down to room temperature, the resulting mixture was quenched by 
addition of water (20 mL), and the aqueous phase extracted with Et2O 
(3 × 25  mL). The combined organic phases were dried over MgSO4, 
filtered and evaporated in vacuo to give a crude mixture, which was 
purified by gel chromatography (hexanes: diethyl ether: acetic acid, 70:30:1 
v:v:v) to afford a white powder. The product was dissolved in 20 mL 
THF and 4 mL 4 n HCl was added dropwise to the solution. After 2 h, 
the deprotection was stopped by addition of an excess of Na2CO3. 
The reaction mixture was diluted with CH2Cl2 (30 mL), washed with 
0.1 m HCl (20 mL), brine (20 mL) and dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude product was purified by 
flash chromatography (hexane/ethyl acetate 3/1) to afford compound 4 
as a white powder. Yield: 0.120 g (92%).
1H NMR (CDCl3, 500 MHz) δ = 5.35 (m, 1H), 3.53 (tt, J = 11.1, 11.1, 4.6, 
4.6, 1H), 3.23 (m, 2H), 2.33–2.20 (m, 2H), 1.98 (m, 2H), 1.84 (m, 3H), 
1.71–1.40 (m, 8H), 1.31–0.90 (m, 16H), 0.69 (s, 3H). 13C NMR (CDCl3, 
126 MHz) δ = 140.74, 121.66, 71.77, 56.71, 55.84, 51.95, 50.07, 42.33, 42.25, 
39.73, 37.22, 36.47, 35.44, 32.90, 31.86, 31.61, 28.19, 25.48, 24.23, 21.04, 
19.37, 18.62, 18.38, 11.84 ppm. HRMS (ESI) calcd for C24H39N3NaO: 
408.2991 [M+ Na]+; found: 408.2995.
Minimize Molecular Modeling Simulations: Lowest energy structures in 
vacuum of molecules were computed using CS Chem3D Ultra software 
employing the MMF94-force field and the steepest-descent algorithm. 
Minimum RMS gradient was set to 0.1; minimum and maximum move 
to 0.000001 and 1.0, respectively. Maximum number of interactions 
moves to 5000.
In Vitro Laurdan Experiments: Large unilamellar vesicles (LUV) 
composed of POPC:chol (90%:10%), POPC:chol-N3 (90%:10%) or 
POPC/chol-N3/chol-N3-AF 647-DBCO (90%: 8%: 2%) were prepared 
following the extrusion method described by.[40] Laurdan was added in 
the organic phase before solvent evaporation. Laurdan labeled liposomes 
at a concentration of 30 × 10−6 m were kept under continuous stirring, 
and the determination of GP profiles at different temperatures 
was performed. All fluorescence measurements were made using 
an SLM Aminco series 2 (Spectronic Instruments, Rochester, NY) 
spectrofluorimeter as previously described.[15] To quantify changes in the 
Laurdan emission spectrum, generalized polarization (GP) values were 
calculated as follow: GP = (IB-IR)/(IB+IR), where IB (at 440 nm) and IR 
(at 490 nm) correspond to the intensities at the blue and red edges of 
the emission maxima, respectively.[41]
Electroformation and Visualization of Giant Unilamellar Vesicles (GUVs): 
Giant unilamellar vesicles (GUVs) were prepared using a homemade 
chamber that allows direct visualization under the microscope.[42] Briefly, 
DOPC/SM/chol (3:3:1, mol/mol) or DOPC/SM/chol-N3 (3:3:1, mol/mol) 
were prepared to a final concentration of 0.2 × 10−3 m in chloroform/
methanol (2:1, v/v), plus 0.2% Rho-DHPE (marker for Ld phases) and 
0.5% of NAP (marker for L0 phases). For in situ chol-N3 labeling, DOPC/
SM/chol-N3 (3:1:1, mol/mol) GUVs containing 0.2% Rho-PE and 1% 
GM1 (ganglioside) were prepared to a final concentration of 0.2 × 10−3 m. 
Next, 2 µl of the lipid mixture stock was spread on the platinum wires 
of the electroformation chamber and organic solvent traces removed by 
placing the chamber under high vacuum for 45 min. Chamber was then 
equilibrated at 70 °C for 15 min followed by addition of 500 µl of 70 °C 
preheated Millie Q water. An AC electrical field, 10 Hz, 2.5 Vpp, was 
then applied for 2 h to the electrodes using a wave generator (TG330 
function generator; Thurlby Thandar Instruments, Huntingdon, UK). 
After switching off the generator, vesicles were left to equilibrate for 
30 min at room temperature. GUVs attached to the platinum electrodes 
were visualized using a Nikon D-eclipse C1 confocal system (Nikon Inc., 
Melville, NY, USA). For in situ analog labeling, 1% of chol-N3 was labeled 
in situ with AF 488-DBCO for 30 min. After extensive washing, cholera 
toxin conjugated AF 647 (3 µg mL−1) was added to the mixture, which 
binds GM1 and labels the Lo phase.
Langmuir Experiments: The NIMA Langmuir-Blodgett Trough 
(Coventry, England) was custom designed with a continuously enclosed 
Teflon-vitrified coated ribbon replacing classical barriers as used 
elsewhere.[16] Surface pressure was quantified with a soaked Wilhelmy 
cellulose plate. The trough was filled with 0.9% saline (pH 5.8) and 
left to reach 25 °C prior to deposition of chol variants. Pressure 
control experiments were carried out by setting the Langmuir Trough 
to maintain 30 mN m−1 and adding 3.25 × 10−8 mol chol diluted to 
13 × 10−3 m in a mixture of chloroform/methanol. 1% or 2% molar ratios 
of chol-N3-AF647, or a 1% molar ratio of DPPC as a positive control. 
To produce the isotherms seen in Figure S6 (Supporting Information), 
deposition of 0.0126 mg chol-N3 or chol-N3 fluorescently labelled 
with AF647-DBCO diluted in chloroform-methanol (at 13 × 10−3 and 
1.2 × 10−3 m, respectively). Compressions were completed at a rate of 
50 cm2 min−1 to produce surface pressure-area isotherms.
Competition Experiments: A competition assay was designed to test 
chol-N3 and fluorescently pre-labeled chol-N3 uptake by cells. HeLa cells 
were seeded onto coverslips in DMEM supplemented with 10% FBS, 
and coincubated with a fixed concentration of chol-N3 (5 × 10−6  m) or 
with chol-N3 (5 × 10−6 m) labeled with 10 × 10−6 m AF 488-DBCO and an 
increasing concentration of natural chol (ranging from 0 to 1 × 10−3 m) 
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added externally to the cells. After 1 h coincubation of cells with the 
mixture, cells were stained in vivo with 5 × 10−6  m AF 488-DBCO for 
60 min, counterstained with DAPI, fixed, and imaged using a ZEISS 
apotome. Alternaltively, HeLa cells were treated with 5 × 10−6 m Bodipy-
chol in DMEM supplemented with 10% FBS and coincubated with 
increasing concentration of natural chol (0–1 × 10−3 m) for 1 h. Cells were 
fixed, and counterstained with DAPI.
Cytotoxicity Experiments: Cytotoxicity of chol-N3 was evaluated by 
measuring LDH release in treated HeLa and primary neuron cells 
with the CytoTOX 96 Non-Radioactive Cytotoxicity Assay (Promega) 
according to the manufacturer’s instructions. Cells were treated with 
either 15 × 10−6 m chol-N3 or 0.2% ethanol in culture medium, or left 
untreated for 18 h at 37 °C with 5% CO2. Positive control cell samples 
were lysed with 10% Lysis Solution for 45’ at 37 °C with 5% CO2. Fresh 
cell culture medium was used as negative control. Cytotoxicity was 
calculated as follow: (average sample absorbance at 490 nm – average 
absorbance of the negative control)/(average absorbance of the positive 
control 490 nm – average absorbance of the negative control) × 100.
Fusogenic Liposome Preparation: Fusogenic liposomes for effective 
chol-N3 delivery onto brain tissue were prepared as previously described 
in.[43] Briefly, liposomal lipid components were mixed in chloroform in a 
molar ratio DOTAP/DOPE/chol-N3 or DOTAP/DOPE/chol (1/1/0.1). The 
lipid was deposited as a film on the wall of a glass test tube by solvent 
evaporation under nitrogen. Solvent traces were removed by placing the 
sample 1 h in a vacuum chamber. Next, the lipid film was suspended 
in artificial cerebral spinal fluid buffer (ACSF; in × 10−3 m, NaCl 125, 
NaHCO3 25, KCl 2.5, NaH2PO4 1.25, glucose 25, CaCl2 2, MgCl2) by 
vortexing at room temperature to form multilamellar vesicles. Finally, 
homogenization of the sample in an ultrasonic bath for 15 min produces 
mainly unilamellar vesicles.
Cell Culture and Maintenance: Human cervix adenocarcinoma HeLa 
cells and human bone marrow neuroblastoma SH-SY5Y cells were 
obtained from ATCC. HeLa cells were maintained in DMEM (Dulbecco’s 
modified Eagle’s medium) supplemented with 10% FBS, 2 × 10−3 m 
Glutamax, 100 units mL−1 penicillin, and 100 µg mL−1 streptomycin (Life 
Technologies) at 37 °C with 5% CO2. SH-SY5Y cells were maintained 
in DMEM/F12 (F12 and Dulbecco´s modified Eagle’s medium) 
supplemented with 10% FBS and 1% penicillin and streptomycin. (Life 
Technologies) at 37 °C with 5% CO2.
Ethics Statement: Animal husbandry and all experimental procedures 
involving rats were approved by the animal ethics committee of 
the University of the Basque Country and by the local authorities 
(authorization number: CEEA M20-2018-97 and 99) and were conducted 
in accordance with the Directives of the European Union on animal 
ethics and welfare.
Preparation and Maintenance of Cultured Neurons: Primary cultures 
of embryonic rat day 18 (E18) (strain Sprague-Dawley) cortical neurons 
were prepared by using standard procedures; animal dissection was 
set as DIV0 (Day In Vitro zero). Briefly, cortical cells were dissociated 
with 0.25% trypsin and 0.1 mg mL−1 DNAse for 15 min at 37 °C, then 
resuspended by gentle trituration with a Pasteur pipette in MEM 
(Minimum Essential Medium) with 10% horse serum and 0.6% 
glucose. 2.5 × 105 neurons were plated onto poly-L-lysine-coated glass-
bottom Petri dishes (Ibidi) or coverslips in MEM-HS-glucose. After 
3 h, the medium was replaced with Neurobasal A medium containing 
B27 supplement and 2 × 10−3 m Glutamax (Invitrogen) and neurons 
were incubated at 37 °C in a humidified incubator with 5% CO2 during 
6 days. At DIV7 and DIV14, 1/5 volume of the medium was replaced with 
fresh Neurobasal medium with 2% B27. At DIV7 2.5 × 10−6 m cytosine 
arabinoside was added to the medium.
Live-Cell Imaging: Cortical neurons (DIV14) were seeded onto poly- 
L-lysine-coated glass-bottom Petri dishes (Ibidi 81158) in media 
Neurobasal A containing B27 serum. Neurons were labeled with 15 × 10−6 m 
chol-N3 for 16 h at 37 °C. Neurons were then washed with 3 × 1000 µL 
PBS, then incubated with 10 × 10−6 m AF 555-DBCO in media for 30 min 
at 37 °C. Finally, cells were extensively washed to remove nonreacted 
probe and immediately proceed for imaging by confocal microscopy 
using either a Zeiss LSM880 with Airyscan and a Plan-Aprochromat 
63x/1.40 oil objective, a Leica TCS SP5 with a Plan-Apochromat 63x/1.30 
glycerol objective, or a LEICA SP8 3X STED SMD confocal microscope 
(Leica Microsystems, Manheim, Germany) with an HCX PL APO 
63x/1.2NA CORR CS2 water immersion objective. Images were further 
processed using Imaris imaging software (Bitplane) or Huygens, SVI 
(Netherlands).
STED Nanoscopy: SH-SY5Y cells were seeded onto imaging dishes 
(Ibidi 81156) in media DMEM/F12 and treated with 25 or 15 × 10−6  m 
chol-N3 for 16 h at 37 °C. Next day, cells were washed and subjected 
to in vivo labeling with different concentrations of AF 488-DBCO, AF 
555-DBCO, or AF 647-DBCO for 30 min at 37 °C followed by extensive 
washing (3 × 1000 µL PBS) to remove unreacted probe and proceed for 
imaging. For dual-color SRM experiments, SH-SY5Y cells were seeded 
onto imaging dishes (Ibidi 81156) in media DMEM/F12 and CD59-
SNAP tag vector (1µg) were transfected using FuGENE HD following 
manufacters instructions and treated with 15 × 10−6 m chol-N3 for 16 h. 
Finally, SNAP-tag CD59 protein and chol-N3 were labelled with cell 
surface SNAP-tag AF 647 (5 × 10−6 m) and AF 488-DBCO (10 × 10−6 m), 
respectively for 30 min at 37 °C. Cells were washed extensively (3 × 
1000 µL PBS) and visualized immediately by LSCM and STED nanoscopy. 
Cortical neurons (DIV14) were seeded onto poly-L-lysine-coated imaging 
dishes (Ibidi 81158) in media (Neurobasal A containing B27 serum). 
Neurons were labeled with 15 × 10−6 m chol-N3 for 16 h at 37 °C. Neurons 
were then washed with 3 × 1000 µL PBS, then incubated with 10 × 10−6 m 
AF 488-DBCO in media for 30 min at 37 °C. Finally, cells were extensively 
washed to remove nonreacted probe and immediately proceed for 
microscopy. STED and LSCM images were taken in a commercial LEICA 
SP8 3X STED SMD confocal microscope (Leica Microsystems, Manheim, 
Germany) equipped with the STED white 100x NA1, 40 oil objective. The 
microscope was equipped with 3 depletion lines and for this work; the 
592 nm depletion line was used. The excitation laser beam consisted 
of a pulsed (80 MHz) super-continuum white light laser (WLL). For a 
cleaner emission, the excitation lines were used a notch filter (NF488) 
in the optical pathway. The pinhole was set at one Airy unit. The gated 
HyD detectors were set with the gated option on and the temporal gated 
selected was from 2 to 6.5 ns when depleting at 592 nm. Imaging and 
processing have been done employing either commercial (Leica LAXs, 
Huygens, SVI) or open source software (ImageJ); analysis and graphing, 
employing EXCEL (Microsoft) or Origin Pro (OriginLab).
In Vivo Laurdan Experiments: Cortical neurons (DIV14) or SH-SY5Y 
cells were seeded onto poly-L-lysine-coated glass-bottom Petri dishes 
(Ibidi 81158) in media Neurobasal A containing B27 serum or DMEM/
F12 media, respectively. Cells were labeled with 15 × 10−6  m chol-N3 
for 16 h at 37 °C. Cells were then washed with 3 × 1000  µL PBS, then 
incubated with 10 × 10−6 m AF 488-DBCO or 10 × 10−6 m AF 647-DBCO, 
and 2.5 × 10−6  m Laurdan in media for 30 min at 37 °C. Next cells 
were extensively washed with PBS (3 × 1000 µL PBS) and imaged on 
a LEICA SP8 3X STED SMD confocal microscope (Leica Microsystems, 
Manheim, Germany), with a HCX PL APO 63x/1.2NA CORR CS2 water 
immersion objective and using solid state laser excitation at 405 nm 
and measuring the intensity between 420 and 460 nm and 470–510 nm 
for later Laurdan GP quantification. Over 10 different regions of interest 
at different areas of the acquired images were analysed using simFCS 
(G-SOFT Inc., Champaign, IL). GP values were represented frequency 
histograms and were nonlinearly fitted to two Gaussian distributions 
using OriginPro (OriginLab, Northampton, MA). Only those fits were 
considered acceptable for which the chi-square test gave values of p > 0.95. 
Experiments were performed independently at least three times.
LIESS-FCS Experiments: SH-SY5Y cells were seeded onto imaging 
dishes (Ibidi 81156) in media DMEM/F12 and treated with 15 × 
10−6  m chol-N3 for 16 h at 37 °C. Cells were labelled with 10 × 10−6  m 
AF 488-DBCO for 30 min at 37 °C and extensively washed with PBS. 
Line interleaved excitation and stimulated emission depletion FCS 
(LIESS-FCS) scanning was recorded on a LEICA SP8 3X STED SMD 
confocal microscope (Leica Microsystems, Manheim, Germany), with a 
HCX PL APO 63x/1.2NA CORR CS2 water immersion objective using the 
line step function and alternating the excitation between the confocal 
and the STED modes between every scanned line, in a similar fashion 
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as described before,[28] but in a line rather than circular scanning. 
Finally, the obtained intensity data for confocal and STED modes were 
extracted into two different channels. For this work, STED and confocal 
observation spot size 100 and 240 nm, respectively, were used. The 
values of Drat = Dap(STED)/Dapp (confocal) over the x axis were obtained 
as previously described.[28] Analysis of the data was done employing 
custom-built software FOCUScan as described before[44] and freely 
available (see the Supporting Information in the paper). The transit 
time ratios (Drat) between the diffusion coefficient values obtained from 
the analysis of the scanning FCS in STED and in confocal mode were 
graphed as a function of the number of events (occurrence) employing 
OriginPro (OriginLab, USA).
RICS Experiments: SH-SY5Y cells were seeded onto imaging dishes 
(Ibidi 81156) in media DMEM/F12 and treated with 15 × 10−6  m chol-
N3 for 16 h at 37 °C. Cells were labelled with 10 × 10−6 m AF 488-DBCO 
for 30 min at 37 °C and extensively washed with PBS. RICS acquisitions 
were recorded on a commercial LEICA SP8 3X STED SMD confocal 
microscope (Leica Microsystems, Manheim, Germany), with an HCX 
PL APO 63x/1.2NA CORR CS2 water immersion objective and using a 
WLL as pulsed laser source. Relative power, as it appears in the LAXs 
software was always below 2%. The images shown are representative 
of the experiments used for quantification out of a larger set of time 
lapses that were also analysed for statistical purposes. Diffusion analysis 
by raster image correlation spectroscopy (RICS) was analysed using 
SimFCS 4 software (G-SOFT Inc.) as previously described in.[45] Point 
spread function was determined as described elsewhere.[45] RICS images 
series (256 × 256 pixels) were taken using either an 8, or 4µs dwell time 
with no difference in the diffusion yielded between them. Each time lapse 
was taken for 200–300 total frames. From each full-frame time-lapse, a 
smaller region of interest was selected (32 × 32 pixels) and diffusion 
coefficient was obtained by fitting the experimental 2D autocorrelation 
function to a single diffusion mode. The 2D autocorrelation map was 
then fitted to obtain a surface map, employing the characterized waist 
value and the appropriate acquisition values for line time and pixel time.
Acute Brain Slices Experiments: 500–1000 µm slices were prepared 
from adult animals (6 to 7 weeks old) with a McIllwain tissue chopper 
and incubated at 30 °C in artificial cerebral spinal fluid (ACSF; in × 
10−3 m, NaCl 125, NaHCO3 25, KCl 2.5, NaH2PO4 1.25, glucose 25, CaCl2 
2, MgCl2 1) oxygenated by a 95/5 (v/v) O2/CO2 gas mixture. Slices were 
metabolically labeled, in situ, with fusogenic liposome composed of 
DOPE/DOTAP/chol-N3 (1/1/0.1) in ACSF for 2 h. After washing, slices 
were subjected to Copper-free click chemistry labelling using 50 × 10−6 m 
cy3-DBCO for 3 h. After extensive washing to remove nonreacted probe, 
tissue was fixed in 4% paraformaldehyde for 25 min. As a final step, fixed 
brain tissue was embedded 24 h in a mounting media composed of 70% 
sorbitol in PBS buffer containing 0.01% sodium azide, which help to align 
the refractive index of the objectives and tissue confering higher-resolution 
and imaging depth. Samples were imaged by Leica Microsystems using a 
Leica TCS SP5 confocal microscope with the Leica HC Fluotar 10/0.3, HC 
Apochromat 20/0.77, and HC Apochromat 40/0.75. Image reconstructions 
were performed using Imaris Imaging software (BItplane). After imaging, 
samples were store in PBS containing 0.01% sodium azide at 4 °C.
Statistics: Data were analyzed using SPSS statistics software. Results 
of Kruskal Wallis test are indicated by: not significant (ns) (p > 0.05), * 
(p < 0.05), ** (p < 0.01), and ***(p < 0.001).
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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